Zoekresultaten - 44 results
Triage of HPV positive women in cervical cancer screening.
Cervical Intraepithelial Neoplasia Colposcopy DNA Methylation DNA, Viral Early Detection of Cancer Female Genotype Genotyping Techniques Human Papillomavirus DNA Tests Humans Mass Screening Papillomaviridae ...
VALGENT: A protocol for clinical validation of human papillomavirus assays.
Detection of Cancer Female Genotyping Techniques Human Papillomavirus DNA Tests Humans Mass Screening middle aged Papillomaviridae Papillomavirus Infections Reagent Kits, Diagnostic Uterine Cervical Neoplasms ...
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
expert team in 2009, based on reproducibility and relative sensitivity and specificity compared to Hybrid Capture-2 or GP5 +/6+ PCR-enzyme immunoassay. These latter two hrHPV DNA assays were validated in ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Trottier, Helen Source: Lancet Oncol, Volume 15, Issue 12, p.1319-31 (2014) Keywords: Carcinogenesis Cyclin-Dependent Kinase Inhibitor p16 DNA, Viral Head and Neck Neoplasms Human papillomavirus 16 Humans ...
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis
Trottier, Helen Source: The Lancet Oncology, Volume 15, Issue 12 (2014) Keywords: HPV DNA meta-analyses neck cancer Abstract: BACKGROUND We aimed to provide updated information about the global estimates of ...
HPV testing and vaccination in Europe.
Papillomavirus DNA Tests Humans Papillomaviridae Papillomavirus Infections Papillomavirus Vaccines Uterine Cervical Neoplasms Vaccination Abstract: Current cytology-based screening has a moderate sensitivity to ...
Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
region was 12.6%, with HPV16 being the most frequent HPV type. The overall HPV DNA prevalence in women with high-grade cervical lesions was 78.1%. HPV DNA was found in 86.6% of cervical cancers; the ...
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
J Source: Cochrane Database Syst Rev, Issue 3, p.CD008054 (2013) Keywords: Cervical Intraepithelial Neoplasia DNA, Viral Female Humans Papillomaviridae Papillomavirus Infections Sensitivity and Specificity ...
The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.
Jerome L; Monsonego, Joseph Source: Int J Cancer, Volume 132, Issue 1, p.101-8 (2013) Keywords: Adult Cervical Intraepithelial Neoplasia DNA, Viral Early Detection of Cancer Female Human Papillomavirus DNA ...
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
substantially lower compared to repeat cytology. The APTIMA (®) test is more specific than HC2 without showing a loss in sensitivity. Identification of DNA of HPV types 16 and/or 18, or RNA from the five most ...